Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,448.93
(
1.66%
)
US TECH 100
22,700.00
(
1.65%
)
Dow Jones
45,791.80
(
1.27%
)
Brent Oil
106.99
(
-1.46%
)
Bitcoin
67,146.95
(
0.67%
)
News Focus
News Focus
Post# of 257320
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122828
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: go seek post# 53175

Thursday, 10/04/2007 12:36:15 AM

Thursday, October 04, 2007 12:36:15 AM

Post# of 257320
Re: VRUS quiz

>to gather additional safety and efficacy data vs Hepsera?<

I’m not asking why Hepsera is in the control arms. The question I’m asking is why only one of the four arms—the Hepsera arm in the e- trial—is different from the other three arms in that it does not stop treatment to test for SVR.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up